Loading stock data…
Scilex Holding Company (SCLX)
$7.80+0.69 (+9.70%)
Market ClosedLast close Jun 29
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Scilex Holding Company in the Healthcare sector is trading at $7.80 with a market capitalization of $53M. The stock is currently 63% below its 52-week high of $21.34, remaining 0.3% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $8.61M↑ | $4.79M↓ | $10.56M↑ | $9.90M↑ | $5.00M |
| Gross Profit | $4.17M↑ | $2.18M↓ | $7.23M↑ | $6.62M↑ | $3.62M |
| Operating Income | -$32.17M↑ | -$37.48M↑ | -$186.51M↓ | -$20.41M↑ | -$27.90M |
| Net Income | -$43.27M↓ | -$33.11M↑ | -$257.23M↓ | -$42.31M↓ | -$26.08M |
Peer Comparison
JNJUNHPFE
Fundamentals
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescript...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$52.54M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.71
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
150.84%
Volume
Today's trading volume
47,823
Recent News
Wellgistics Health, Datavault AI Agree to Form DelivMeds AI
Wellgistics Health (WGRX) and Datavault AI (DVLT) said Wednesday they have entered a binding term sh
Datavault AI Signs Binding Term Sheet for $120 Million Cash Contribution From Scilex
Datavault AI (DVLT) said Monday it has signed a binding term sheet for a cash contribution and reven
Trending tickers: Datavault, Novo Nordisk, FedEx, SBI and NatWest
The latest investor updates on stocks that are trending on Monday
Scilex Holding Company's (NASDAQ:SCLX) top owners are retail investors with 57% stake, while 24% is held by private companies
Key Insights Scilex Holding's significant retail investors ownership suggests that the key decisions are influenced by...
Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
Datavault AI's multi-million-dollar geothermal deal and guidance upgrade signal that its strategic pivot to AI data monetization is gaining traction.